Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-065179
Filing Date
2026-02-24
Accepted
2026-02-24 06:56:16
Documents
107
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apls-20251231.htm   iXBRL 10-K 4815629
2 EX-10.26 apls-ex10_26.htm EX-10.26 46097
3 EX-10.31 apls-ex10_31.htm EX-10.31 75715
4 EX-10.32 apls-ex10_32.htm EX-10.32 58205
5 EX-10.33 apls-ex10_33.htm EX-10.33 51371
6 EX-21.1 apls-ex21_1.htm EX-21.1 28214
7 EX-23.1 apls-ex23_1.htm EX-23.1 3626
8 EX-31.1 apls-ex31_1.htm EX-31.1 17851
9 EX-31.2 apls-ex31_2.htm EX-31.2 17861
10 EX-32.1 apls-ex32_1.htm EX-32.1 10540
11 EX-32.2 apls-ex32_2.htm EX-32.2 10287
12 GRAPHIC img23129386_0.jpg GRAPHIC 42889
13 GRAPHIC img23129386_1.jpg GRAPHIC 79161
14 GRAPHIC img23129386_2.jpg GRAPHIC 25354
15 GRAPHIC img23129386_3.jpg GRAPHIC 55912
16 GRAPHIC img23129386_4.jpg GRAPHIC 142000
17 GRAPHIC img112562093_0.jpg GRAPHIC 13590
  Complete submission text file 0001193125-26-065179.txt   19656721

Data Files

Seq Description Document Type Size
18 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apls-20251231.xsd EX-101.SCH 2332420
110 EXTRACTED XBRL INSTANCE DOCUMENT apls-20251231_htm.xml XML 3726967
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38276 | Film No.: 26667412
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)